$PRLB
Proto Labs Inc Stock $prlb

$prlb Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923012837 Filed on May 05, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$122.3M	$125.9M	$124.2M
YoY Change	-3.65%	1.36%	6.93%
Cost Of Revenue	$69.14M	$72.08M	$68.36M
YoY Change	-0.49%	5.44%	12.45%
Gross Profit	$53.12M	$53.78M	$55.80M
YoY Change	-7.49%	-3.63%	0.86%
Gross Profit Margin	43.45%	42.73%	44.94%
Selling, General & Admin	$37.55M	$39.28M	$37.36M
YoY Change	-0.07%	5.16%	-3.94%
% of Gross Profit	70.69%	73.05%	66.94%
Research & Development	$9.865M	$10.68M	$10.56M
YoY Change	4.39%	1.14%	-13.33%
% of Gross Profit	18.57%	19.85%	18.92%
Depreciation & Amortization	$9.495M	$9.388M	$10.23M
YoY Change	-5.45%	-8.25%	1.72%
% of Gross Profit	17.87%	17.46%	18.34%
Operating Expenses	$47.42M	$50.03M	$47.91M
YoY Change	-9.2%	4.41%	-6.18%
Operating Profit	$5.706M	$3.749M	$7.890M
YoY Change	9.71%	-52.48%	85.17%
Interest Expense	-$3.368M	$1.290M
YoY Change
% of Operating Profit	-59.03%	34.41%
Other Income/Expense, Net	-$3.368M	$1.290M	-$300.0K
YoY Change	-336900.0%	-530.0%	-4.15%
Pretax Income	$2.240M	$5.039M	$7.590M
YoY Change	-56.94%	-33.61%	92.25%
Income Tax	$2.623M	$2.400M	$2.500M
% Of Pretax Income	117.1%	47.63%	32.94%
Net Earnings	-$383.0K	$2.659M	$5.095M
YoY Change	-114.98%	-47.81%	37.26%
Net Earnings / Revenue	-0.31%	2.11%	4.1%
Basic Earnings Per Share	-$0.01	$0.10	$0.19
Diluted Earnings Per Share	-$0.01	$0.10	$0.19
COMMON SHARES
Basic Shares Outstanding	26.20M	26.68M	27.50M
Diluted Shares Outstanding	26.21M shares	26.61M	27.51M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$86.44M	$84.90M	$77.15M
YoY Change	9.35%	10.04%	21.69%
Cash & Equivalents	$66.49M	$62.05M	$57.24M
Short-Term Investments	$19.95M	$22.85M	$19.91M
Other Short-Term Assets	$8.501M	$11.10M	$10.19M
YoY Change	-25.98%	8.99%	15.74%
Inventory	$14.31M	$14.27M	$14.23M
Prepaid Expenses
Receivables	$75.03M	$77.62M	$85.96M
Other Receivables	$868.0K	$821.0K	$687.0K
Total Short-Term Assets	$185.2M	$188.7M	$188.2M
YoY Change	-2.9%	0.27%	18.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$268.6M	$253.6M	$270.9M
YoY Change	3.07%	-6.4%	-3.2%
Goodwill	$274.0M	$274.0M	$398.3M
YoY Change	-29.81%	-31.21%	-0.28%
Intangibles
YoY Change
Long-Term Investments	$16.34M	$19.82M	$28.20M
YoY Change	-47.39%	-29.69%	-5.38%
Other Assets	$4.738M	$4.776M	$4.286M
YoY Change	12.2%	11.43%	-12.03%
Total Long-Term Assets	$592.1M	$602.7M	$746.5M
YoY Change	-18.67%	-19.27%	-3.79%
TOTAL ASSETS
Total Short-Term Assets	$185.2M	$188.7M	$188.2M
Total Long-Term Assets	$592.1M	$602.7M	$746.5M
Total Assets	$777.2M	$791.4M	$934.8M
YoY Change	-15.4%	-15.34%	0.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.47M	$19.85M	$17.51M
YoY Change	5.32%	13.38%	-19.84%
Accrued Expenses	$32.85M	$39.15M	$38.38M
YoY Change	-23.32%	2.0%	23.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$16.55M	$17.45M	$493.0K
YoY Change	3695.64%	3439.96%	-17.83%
Total Short-Term Liabilities	$66.22M	$78.38M	$60.25M
YoY Change	12.4%	30.09%	0.67%
LONG-TERM LIABILITIES
Long-Term Debt	$745.0K	$0.00	$1.269M
YoY Change	-37.29%	-100.0%	-29.5%
Other Long-Term Liabilities	$6.769M	$4.615M	$6.021M
YoY Change	17.03%	-23.35%	-2.37%
Total Long-Term Liabilities	$7.514M	$4.615M	$6.021M
YoY Change	29.91%	-23.35%	-2.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$66.22M	$78.38M	$60.25M
Total Long-Term Liabilities	$7.514M	$4.615M	$6.021M
Total Liabilities	$94.53M	$108.2M	$102.7M
YoY Change	-3.5%	5.37%	-15.12%
SHAREHOLDERS EQUITY
Retained Earnings	$246.9M	$251.4M	$381.8M
YoY Change	-35.2%	-34.15%	4.15%
Common Stock	$465.0M	$465.2M	$472.5M
YoY Change	-2.27%	-1.54%	3.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$682.7M	$683.1M	$832.0M
YoY Change
Total Liabilities & Shareholders Equity	$777.2M	$791.4M	$934.8M
YoY Change	-15.4%	-15.34%	0.03%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$383.0K	$2.659M	$5.095M
YoY Change	-114.98%	-47.81%	37.26%
Depreciation, Depletion And Amortization	$9.495M	$9.388M	$10.23M
YoY Change	-5.45%	-8.25%	1.72%
Cash From Operating Activities	$9.289M	$22.58M	$17.78M
YoY Change	-29.93%	26.96%	176.78%
INVESTING ACTIVITIES
Capital Expenditures	$3.388M	$3.441M	$3.069M
YoY Change	-214.42%	12.12%	-53.12%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$6.819M	$7.824M	-$22.77M
YoY Change	-188.33%	-134.37%	-72.77%
Cash From Investing Activities	$3.431M	$4.383M	-$25.84M
YoY Change	-132.12%	-116.97%	-71.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-8.064M	-$21.60M	-$601.0K
YoY Change	91.09%	3494.34%	40.75%
NET CHANGE
Cash From Operating Activities	9.289M	$22.58M	$17.78M
Cash From Investing Activities	3.431M	$4.383M	-$25.84M
Cash From Financing Activities	-8.064M	-$21.60M	-$601.0K
Net Change In Cash	4.656M	$5.493M	-$8.690M
YoY Change	-383.21%	-163.21%	-89.63%
FREE CASH FLOW
Cash From Operating Activities	$9.289M	$22.58M	$17.78M
Capital Expenditures	$3.388M	$3.441M	$3.069M
Free Cash Flow	$5.901M	$19.14M	$14.71M
YoY Change	-63.61%	30.06%	-12260.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Proto Labs Inc
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26202723
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26202723
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26888425
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26888425
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17532000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4776000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4779000	usd
CY2023Q1	us-gaap	Assets Assets	791373000	usd
CY2022Q4	us-gaap	Assets Assets	802168000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	19854000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17356000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14695000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12743000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	23156000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	22384000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1295000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1561000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17452000	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001443669
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17537000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1928000	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1932000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1706000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-35435
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1939628
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5540 Pioneer Creek Drive
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Maple Plain
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55359
CY2023Q1	dei	City Area Code CityAreaCode	763
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	479-3680
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.001 Per Share
CY2023Q1	dei	Trading Symbol TradingSymbol	PRLB
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26202723
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62051000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56558000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	22851000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	23568000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	77619000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76225000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	14273000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	13578000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	821000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4042000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11101000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12597000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	188716000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	186568000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	253616000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	257785000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	273991000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	273991000	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	29869000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	31250000	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	19824000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	26419000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3315000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3844000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17266000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	78380000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	71581000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1983000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2255000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	23258000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	26322000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4615000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4362000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	108236000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	104520000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	26000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	27000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	465185000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	473740000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	251420000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	258236000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33494000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-34355000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	683137000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	697648000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	791373000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	802168000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	125859000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	124168000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	72083000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	68364000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	53776000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	55804000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22451000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20586000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10677000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10557000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16833000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16771000	usd
CY2023Q1	prlb	Disposal Group Operating Expense DisposalGroupOperatingExpense	66000	usd
CY2022Q1	prlb	Disposal Group Operating Expense DisposalGroupOperatingExpense	0	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	50027000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	47914000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3749000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7890000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1290000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-300000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5039000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7590000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2380000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2495000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2659000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5095000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26580279
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27502941
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26605787
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27510477
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3520000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-393000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	697648000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-401000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3695000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	21325000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2659000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	527000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	334000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3520000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	683137000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	828493000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-462000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4397000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5095000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4972000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-516000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-393000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	832035000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2659000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5095000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9388000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10232000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3695000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4397000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3096000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3213000	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	287000	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	0	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-46000	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	79000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2328000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6329000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	641000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	675000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1464000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1110000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5160000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4519000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2536000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-326000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3500000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2894000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22578000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17783000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3441000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3069000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	194000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	29366000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	7630000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	6600000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4383000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25835000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	6000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	401000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	468000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	21119000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	82000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	139000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21602000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-601000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	134000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-37000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5493000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8690000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56558000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	65929000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	62051000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	57239000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	382906
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	233380
CY2023Q1	us-gaap	Inventory Net InventoryNet	14273000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2659000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5095000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26580279
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27502941
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	25508
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7536
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26605787
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27510477
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53751000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23882000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29869000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53588000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	22338000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31250000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	1500000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	1700000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4376000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3746000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3648000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3546000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3537000	usd
CY2023Q1	prlb	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	11016000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29869000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	13578000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3700000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4400000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	43720000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1045000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	42675000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	51366000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1379000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	49987000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	22851000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	19824000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	42675000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	14692000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	13965000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	419000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	387000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	263992
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	79.07
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	134647
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	33.84
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15061
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	73.17
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	672
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	108.33
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	382906
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	63.34
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	120344
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	89.42
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.21
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2400000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2500000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.472	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.329	pure
CY2023Q1	prlb	Effective Income Tax Rate Continuing Operations Increase Decrease During The Period EffectiveIncomeTaxRateContinuingOperationsIncreaseDecreaseDuringThePeriod	0.143	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4700000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4500000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3749000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7890000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	253616000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	257785000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	125859000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	124168000	usd

Files In Submission

Name	View Source	Status
0001437749-23-012837-index-headers.html	Edgar Link	pending
0001437749-23-012837-index.html	Edgar Link	pending
0001437749-23-012837.txt	Edgar Link	pending
0001437749-23-012837-xbrl.zip	Edgar Link	pending
ex_470548.htm	Edgar Link	pending
ex_470549.htm	Edgar Link	pending
ex_470550.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prlb-20230331.xsd	Edgar Link	pending
prlb20230331c_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
prlb-20230331_cal.xml	Edgar Link	unprocessable
prlb-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
prlb-20230331_pre.xml	Edgar Link	unprocessable
prlb-20230331_lab.xml	Edgar Link	unprocessable
prlb20230331c_10q_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRLB
Proto Labs Inc Stock $prlb

2023 Q2 Form 10-Q Financial Statement

#000143774923012837 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRLB Proto Labs Inc Stock $prlb

2023 Q2 Form 10-Q Financial Statement

#000143774923012837 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRLB
Proto Labs Inc Stock $prlb